Organization
University of Alberta, Edmonton, Canada
10 abstracts
Abstract
14-3-3 ETA MARKS RADIOGRAPHIC PROGRESSION IN AN EARLY ARTHRITIS COHORT Org: Jan van Breemen Research Institute, Reade, Netherlands, Augurex Life Sciences Corp, North Vancouver, Canada, University of Alberta, Edmonton, Canada,
Abstract
14-3-3ETA AS A NOVEL RA DRUG TARGET: ANTI-14-3-3ETA MONOCLONAL ANTIBODY DELAYS THE ONSET AND MITIGATES THE SEVERITY OF ARTHRITIS IN CIA MICE Org: National Research Council, Ottawa, Augurex Life Sciences Corp, North Vancouver, Canada, University of Alberta, Edmonton, Canada,
Abstract
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 16-WEEK STUDY OF SUBCUTANEOUS GOLIMUMAB IN PATIENTS WITH ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS Org: University Clinic Benjamin Franklin, Berlin, Germany, Leiden University Medical Center, Leiden, Netherlands, Paris-Descartes University, Paris, France, University of Alberta, Edmonton, Canada, Merck & Co., Inc., Kenilworth, United States,
Abstract
ARE THERE GENDER SPECIFIC DIFFERENCES IN PATIENT REPORTED OUTCOMES AT INITIATION OF GOLIMUMAB TREATMENT IN RHEUMATOID ARTHRITIS? Org: University of Alberta, Edmonton, Canada, St Joseph's Hospital & McMaster University, Hamilton, Montreal General Hospital, Montreal, Centre de Rhumatologie de l'Est du Québec, Rimouski, University of Saskatchewan, Saskatoon,
Abstract
ASAS MODIFICATION OF THE BERLIN ALGORITHM AND THE DUET ALGORITHM FOR DIAGNOSING AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE SCREENING IN AXIAL SPONDYLOARTHRITIS FOR PSORIASIS, IRITIS, AND COLITIS COHORTOrg: University of Southern Denmark, Sønderborg, Denmark, St. Joseph’s Healthcare Hamilton, Hamilton, Canada, James Yeung Rheumatology, Richmond, Canada, Artus Health Centre, Vancouver, Canada, The Ottawa Hospital, Ottawa, Canada,
Abstract
ADDING ULTRASOUND TO THE TREAT-TO-TARGET STRATEGY SHOWS NO BENEFIT IN ACHIEVEMENT OF REMISSION: RESULTS FROM THE BIODAM COHORT Org: LUMC, Leiden, Netherlands, ARC, Amsterdam, Netherlands, Charité, Berlin, Germany, SVUH, Dublin, Ireland, McMaster University, Hamilton, ON, Canada,
Abstract
ASSOCIATION OF ANKYLOSING SPONDYLITIS SUSCEPTIBILITY SNPS FROM RECENT GWAS IN A CANADIAN PSORIATIC ARTHRITIS COHORT Org: Memorial University of Newfoundland, St. John's, Canada, University of Toronto, Toronto, ON, Canada, University of Alberta, Edmonton, Canada, Newfound Genomics Inc., St. John's, Canada,
Abstract
ASSESSING TREATMENT DURABILITY OF INFLIXIMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS PATIENTS IN A CANADIAN SETTING Org: Mary Pack Arthritis Centre, Vancouver, University of Ottawa, Ottawa, Memorial University of Newfoundland, St. John's, Canada, University of Alberta, Edmonton, Canada, Montreal General Hospital, Montreal,
Abstract
AUTO-ANTIBODIES TO PAN AND CITRULLINATED 14-3-3 ETA ARE EXPRESSED IN ANTI-CCP NEGATIVE RA Org: University of Alberta, Edmonton, Canada, Hospital for Special Surgery, New York, United States of America, Leiden University, Leiden, Netherlands, Academic Medical Center, Amsterdam, Netherlands, Augurex Life Sciences Corp, North Vancouver, Canada,
Abstract
ARE THERE GENDER-SPECIFIC DIFFERENCES IN PATIENT CHARACTERISTICS AT INITIATION OF BIOLOGIC TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS? Org: St. Joseph's Hospital and McMaster University, Hamilton, Mary Pack Arthritis Centre, Vancouver, Nanaimo Regional General Hospital, Nanaimo, University of Alberta, Edmonton, Canada, Centre de Rhumatologie de l'Est du Québec, Rimouski,